Advertisement

Topics

AmpliMed Corporation Company Profile

05:36 EDT 22nd June 2018 | BioPortfolio

AmpliMed Corporation develops novel drugs for the treatment of cancer. Our lead product, Amplimexon™ (imexon inj.), has particular promise for the treatment of pancreatic cancer, malignant melanoma, lung cancer and multiple myeloma. Other products in our portfolio have promise in ovarian, breast, prostate and other common cancers. Our compounds have novel ways of killing cancer cells which are distinct from many other anticancer drugs. They may also avoid some of the toxicity which is common in cancer drugs, and bypass the resistance mechanisms built up by the cancer cells. This gives our drugs significant potential advantages, enabling them to avoid some of the factors which limit the use of many other cancer chemotherapeutics.

Location

4380 North Campbell Avenue, Suite 205
Tucson
Arizona
85718
United States of America

Contact

Phone: 520.529.1000
Fax: 520.529.3001
Email: rashley@amplimed.com


News Articles [87 Associated News Articles listed on BioPortfolio]

Orion Corporation: Managers' transactions - Ari Lehtoranta

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Ari Lehtoranta Orion Corporation has received the...

Orion Corporation: Managers' transactions - Liisa Hurme

ORION CORPORATION         MANAGERS' TRANSACTIONS 2nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Liisa Hurme Orion Corporation has received...

Orion Corporation: Managers' transactions - Timo Maasilta

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Timo Maasilta Orion Corporation has received the ...

Orion Corporation: Managers' transactions - Sirpa Jalkanen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Sirpa Jalkanen Orion Corporation has received the ...

Orion Corporation: Managers' transactions - Eija Ronkainen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST Orion Corporation: Managers' transactions - Eija Ronkainen Orion Corporation has received...

Orion Corporation: Managers' transactions - Mikael Silvennoinen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST              Orion Corporation: Managers' transactions - Mikael Silvennoinen Orio...

Orion Corporation: Managers' transactions - Heikki Westerlund

ORION CORPORATION      MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST              Orion Corporation: Managers' transactions - Heikki Westerlund Orion Co...

Orion Corporation: Managers' transactions - Ylppö Jukka

ORION CORPORATION         MANAGERS' TRANSACTIONS 03 JANUARY 2018 at 15.10 EET              Orion Corporation: Managers' transactions - Ylppö Jukka Orio...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [175 Associated Companies listed on BioPortfolio]

AmpliMed Corporation

AmpliMed Corporation develops novel drugs for the treatment of cancer. Our lead product, Amplimexon™ (imexon inj.), has particular promise for the treatment of pancreatic cancer, malignant melanoma,...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

NEC Corporation of America

NEC Corporation of America (NEC) is a leading technology integrator providing solutions that improve the way people work and communicate. NEC delivers integrated Solutions for Soc...

Hot Spring Spas

Hot Spring Spas is the world’s leading brand of hot tubs and is sold through a network of more than 700 independent dealers throughout North America and 70 countries around t...

More Information about "AmpliMed Corporation" on BioPortfolio

We have published hundreds of AmpliMed Corporation news stories on BioPortfolio along with dozens of AmpliMed Corporation Clinical Trials and PubMed Articles about AmpliMed Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AmpliMed Corporation Companies in our database. You can also find out about relevant AmpliMed Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record